Remove Clinical Trials Remove Life Science Remove Radiology
article thumbnail

Clinical Trials Day 2024 Recap: Celebrating Progress and Partnerships

XTalks

Yesterday, on International Clinical Trials Day 2024, the global healthcare community came together to commemorate the significant advancements in clinical research and the vital role clinical trials play in improving patient care and outcomes.

article thumbnail

The tech revolution reshaping European healthcare

pharmaphorum

In the European hospital setting, the first to digitise were the picture archiving systems (PACS) in radiology departments then electronic medical records (EMRs), patient administration systems and departmental IT flow work solutions (eg, laboratory information systems and radiology information systems). About the author.

Radiology 135
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unique ADHD Biomarkers Revealed from MRI Data from the Adolescent Brain Cognitive Development Study

XTalks

The study results will be presented at the Radiological Society of North America annual meeting , which is currently being held in Chicago, IL until December 1, 2022. XTALKS WEBINAR: Getting Neuroimaging Right — How to Succeed in Neurodegenerative Clinical Trials. What is ADHD and How is it Diagnosed?

article thumbnail

Bayer delivers on medical innovation fueling transformation of pharma business

The Pharma Data

Our leadership in cardiology, radiology and women’s health is recognized worldwide, and we are expanding our presence in oncology, working tirelessly to bring forward new approaches that can change the treatment paradigm for patients,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceuticals Division.

article thumbnail

Considerations for Mobile Health Technology Developers: Part 2

pharmaphorum

On 27th September 2022, the Food and Drug Administration (FDA) issued its final guidance for industry and FDA staff clinical decision support (CDS) software, which has been anticipated since the Center for Devices and Radiological Health (CDRH) listed the guidance as a top priority for fiscal year 2022.

article thumbnail

World Cancer Day 2024: Trends in Oncology Research and More

XTalks

Clinical trials have demonstrated the potential of CRISPR/Cas9 in this field. Personalized medicine: One of the most exciting prospects of CRISPR/Cas9 in oncology is its contribution to personalized medicine. By tailoring treatments based on an individual’s genetic makeup, it may allow for more effective and targeted therapies.

Research 118
article thumbnail

Bayer’s Gadovist™ (Gadobutrol) at a Reduced Dose Demonstrates Non-Inferiority Compared to a Standard Dose of Gadoterate for CNS Imaging

The Pharma Data

Bayer published today the results of its LEADER-75 (LowEr Administered Dose with highEr Relaxivity) study, demonstrating the clinical efficacy of a reduced dose of gadobutrol compared to a typical dose of gadoterate in patients undergoing a steady-state contrast-enhanced MRI of the CNS. mmol/kg) for CNS imaging. mmol/kg weight. “At